Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.
about
Is NF-kappaB a good target for cancer therapy? Hopes and pitfallsAre we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trialMarine Diterpenoids as Potential Anti-Inflammatory AgentsCritical role of NF-κB in pancreatic cancerCharacterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress ResponsesNF-kappaB and IKK as therapeutic targets in cancerTargeting NF-kappaB in hematologic malignanciesTo NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate RegulatorComplex regulation of neutrophil-derived MMP-9 secretion in central nervous system tuberculosisThe next generation of novel therapies for the management of relapsed multiple myeloma.Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics.Emerging drugs for chronic lymphocytic leukaemia.The Systemic Effect of Burn Injury and Trauma on Muscle and Bone Mass and Composition.Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells.NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation.Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).Anti-inflammatory thalidomide improves islet grafts survival and functions in a xenogenic environmentIn vitro anticancer property of a novel thalidomide analogue through inhibition of NF-kappaB activation in HL-60 cellsThalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC).Thalidomide-a notorious sedative to a wonder anticancer drug.Clinical anticachexia treatments.Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismPomalidomide therapy for multiple myeloma and myelofibrosis: an update.Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta.The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.Thalidomide as an anti-cancer agent.Thalidomide and its derivatives: emerging from the wilderness.Thalidomide: a new anticancer drug?Novel therapeutic approaches for multiple myeloma.Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.Dermatologic and nondermatologic uses of thalidomide.To die or not to die: the function of the transcription factor NF-kappaB in embryos exposed to stress.Thalidomide for the treatment of multiple myeloma.Thalidomide and immunomodulatory drugs in the treatment of cancer.Thalidomide induces gamma-globin gene expression through increased reactive oxygen species-mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis.Agents targeting inflammation in heart failure.Anti-inflammatory effects of bangpungtongsung-san, a traditional herbal prescriptionTherapeutic renaissance of thalidomide in the treatment of haematological malignancies.Euphorbia humifusa Willd exerts inhibition of breast cancer cell invasion and metastasis through inhibition of TNFα-induced MMP-9 expression.
P2860
Q24570128-BE7C3990-966F-440E-882D-625BA57670D7Q24597424-349A5BE3-E435-409B-BB5A-E644161B040DQ24685678-84A6F2E0-AD67-4450-9FF1-24A99FAED699Q26779952-3F66543E-8D6E-4EA9-B2A6-9B4711AB5720Q26864198-D031A05C-7AD7-4BEF-8C9E-8F0DAAE6989AQ28271836-1BA52390-D348-49A9-AA60-9E01D84B7B82Q28297985-34D52BF8-862E-4257-915E-C61314F24B01Q28299055-F6B23431-326A-453B-B141-767430BBFA38Q28386593-5B928BAE-8DC3-4E1D-BBE0-2D27658776AEQ28817395-F6AAA1B8-C3F5-4204-B41F-27F1B583627EQ30248534-10320ACE-8C3E-4240-8F2D-2F97E2411E60Q30278668-67D606C6-980C-43AD-B039-C702403FBA96Q30353154-CB62BE60-0B3B-45A4-ADEB-B336E16FB21AQ30760745-60F10FBC-064A-41FA-931B-FFDF3DBA825AQ30952817-3659211C-A0EC-4C55-881B-4AA7CD28B2A4Q31157266-869CBE69-586D-44D0-9FA9-4AA01206F838Q33391803-7EA00DA6-2B35-4B5F-950D-DD031FB47D3AQ33484188-7684AEF6-5146-4DF8-A8EB-D6573FE10712Q33552178-E090DBCB-4D31-43D2-8E5D-4B0BB9EF7061Q33655628-21515347-B3D0-41D3-A8B4-48F60A10F22BQ33956871-95310F5A-0E7F-4440-B778-90DF216E89ECQ33994400-8317C656-7FB8-4E65-8031-7EADEAAD2F88Q34079481-8DF72541-F5C1-46D4-92E8-129DD8D17D5AQ34165935-185B31FF-F29A-4D44-B711-EC521056ECA8Q34212252-B7C3EA86-1D48-4A16-9AD2-58F20379596EQ34542601-A39263ED-C1E6-45F9-B6A9-CDDC2161E599Q34778074-F2A248D9-9CCF-4D52-ABDF-70E955EEEEC5Q35107977-F7235DBB-6BCC-4561-AF64-762A82D9C5F9Q35164773-1D1D65ED-1C76-4EA5-B82D-D78C6D10FB1BQ35170935-A7D6065D-8385-4BB6-993A-660CBA3D061FQ35171777-EF401EA9-37A5-4568-83FF-FEF4BCE884B6Q35201057-97DEAC96-D1E5-41D2-BB2B-67A803AD45E9Q35641452-B2465BE6-E72C-44AE-8330-784749B4425AQ35870500-8001A2AD-BCAA-4793-9BBA-B2E001560EC1Q36040871-6C302058-54E1-4675-B341-F9F9DD5C5FF3Q36059602-B77CB28E-9077-491A-BDCE-F382F22A62B7Q36145827-5ACD0733-F05D-4322-B0EE-B18C06880BF7Q36148576-380750DD-4B62-4E85-88AA-64AEC885273BQ36171864-EC78BDC7-43A6-4762-B964-7D1347B28A5EQ36173467-4D8E667F-4499-478A-86F1-6D2A24C85919
P2860
Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Inhibition of NF-kappa B activ ...... on of IkappaB kinase activity.
@en
Inhibition of NF-kappa B activ ...... on of IkappaB kinase activity.
@nl
type
label
Inhibition of NF-kappa B activ ...... on of IkappaB kinase activity.
@en
Inhibition of NF-kappa B activ ...... on of IkappaB kinase activity.
@nl
prefLabel
Inhibition of NF-kappa B activ ...... on of IkappaB kinase activity.
@en
Inhibition of NF-kappa B activ ...... on of IkappaB kinase activity.
@nl
P2093
P356
P1476
Inhibition of NF-kappa B activ ...... on of IkappaB kinase activity.
@en
P2093
A S Baldwin
B P Ashburner
D C Guttridge
J A Keifer
P304
22382-22387
P356
10.1074/JBC.M100938200
P407
P577
2001-04-10T00:00:00Z